Table of Content

1 Intramuscular HPV Vaccine Market Overview
1.1 Product Overview and Scope of Intramuscular HPV Vaccine
1.2 Intramuscular HPV Vaccine Segment by Type
1.2.1 Global Intramuscular HPV Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Bivalent
1.2.3 Quadrivalent
1.2.4 Nine-valent
1.3 Intramuscular HPV Vaccine Segment by Application
1.3.1 Global Intramuscular HPV Vaccine Market Value by Application: (2024-2034)
1.3.2 Male
1.3.3 Female
1.4 Global Intramuscular HPV Vaccine Market Size Estimates and Forecasts
1.4.1 Global Intramuscular HPV Vaccine Revenue 2018-2029
1.4.2 Global Intramuscular HPV Vaccine Sales 2018-2029
1.4.3 Global Intramuscular HPV Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Intramuscular HPV Vaccine Market Competition by Manufacturers
2.1 Global Intramuscular HPV Vaccine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Intramuscular HPV Vaccine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Intramuscular HPV Vaccine Average Price by Manufacturers (2018-2024)
2.4 Global Intramuscular HPV Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Intramuscular HPV Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intramuscular HPV Vaccine, Product Type & Application
2.7 Intramuscular HPV Vaccine Market Competitive Situation and Trends
2.7.1 Intramuscular HPV Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intramuscular HPV Vaccine Players Market Share by Revenue
2.7.3 Global Intramuscular HPV Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intramuscular HPV Vaccine Retrospective Market Scenario by Region
3.1 Global Intramuscular HPV Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Intramuscular HPV Vaccine Global Intramuscular HPV Vaccine Sales by Region: 2018-2029
3.2.1 Global Intramuscular HPV Vaccine Sales by Region: 2018-2024
3.2.2 Global Intramuscular HPV Vaccine Sales by Region: 2024-2029
3.3 Global Intramuscular HPV Vaccine Global Intramuscular HPV Vaccine Revenue by Region: 2018-2029
3.3.1 Global Intramuscular HPV Vaccine Revenue by Region: 2018-2024
3.3.2 Global Intramuscular HPV Vaccine Revenue by Region: 2024-2029
3.4 North America Intramuscular HPV Vaccine Market Facts & Figures by Country
3.4.1 North America Intramuscular HPV Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Intramuscular HPV Vaccine Sales by Country (2018-2029)
3.4.3 North America Intramuscular HPV Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intramuscular HPV Vaccine Market Facts & Figures by Country
3.5.1 Europe Intramuscular HPV Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Intramuscular HPV Vaccine Sales by Country (2018-2029)
3.5.3 Europe Intramuscular HPV Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intramuscular HPV Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Intramuscular HPV Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Intramuscular HPV Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Intramuscular HPV Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Intramuscular HPV Vaccine Market Facts & Figures by Country
3.7.1 Latin America Intramuscular HPV Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Intramuscular HPV Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Intramuscular HPV Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Intramuscular HPV Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Intramuscular HPV Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Intramuscular HPV Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Intramuscular HPV Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intramuscular HPV Vaccine Sales by Type (2018-2029)
4.1.1 Global Intramuscular HPV Vaccine Sales by Type (2018-2024)
4.1.2 Global Intramuscular HPV Vaccine Sales by Type (2024-2029)
4.1.3 Global Intramuscular HPV Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Intramuscular HPV Vaccine Revenue by Type (2018-2029)
4.2.1 Global Intramuscular HPV Vaccine Revenue by Type (2018-2024)
4.2.2 Global Intramuscular HPV Vaccine Revenue by Type (2024-2029)
4.2.3 Global Intramuscular HPV Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Intramuscular HPV Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Intramuscular HPV Vaccine Sales by Application (2018-2029)
5.1.1 Global Intramuscular HPV Vaccine Sales by Application (2018-2024)
5.1.2 Global Intramuscular HPV Vaccine Sales by Application (2024-2029)
5.1.3 Global Intramuscular HPV Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Intramuscular HPV Vaccine Revenue by Application (2018-2029)
5.2.1 Global Intramuscular HPV Vaccine Revenue by Application (2018-2024)
5.2.2 Global Intramuscular HPV Vaccine Revenue by Application (2024-2029)
5.2.3 Global Intramuscular HPV Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Intramuscular HPV Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck Sharp & Dohme (MSD)
6.1.1 Merck Sharp & Dohme (MSD) Corporation Information
6.1.2 Merck Sharp & Dohme (MSD) Description and Business Overview
6.1.3 Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Product Portfolio
6.1.5 Merck Sharp & Dohme (MSD) Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Pfizer Intramuscular HPV Vaccine Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Sanofi Intramuscular HPV Vaccine Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 GSK Intramuscular HPV Vaccine Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Serum Institute
6.5.1 Serum Institute Corporation Information
6.5.2 Serum Institute Description and Business Overview
6.5.3 Serum Institute Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Serum Institute Intramuscular HPV Vaccine Product Portfolio
6.5.5 Serum Institute Recent Developments/Updates
6.6 Astellas Pharma
6.6.1 Astellas Pharma Corporation Information
6.6.2 Astellas Pharma Description and Business Overview
6.6.3 Astellas Pharma Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Astellas Pharma Intramuscular HPV Vaccine Product Portfolio
6.6.5 Astellas Pharma Recent Developments/Updates
6.7 CSL
6.6.1 CSL Corporation Information
6.6.2 CSL Description and Business Overview
6.6.3 CSL Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 CSL Intramuscular HPV Vaccine Product Portfolio
6.7.5 CSL Recent Developments/Updates
6.8 Emergent BioSolutions
6.8.1 Emergent BioSolutions Corporation Information
6.8.2 Emergent BioSolutions Description and Business Overview
6.8.3 Emergent BioSolutions Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Emergent BioSolutions Intramuscular HPV Vaccine Product Portfolio
6.8.5 Emergent BioSolutions Recent Developments/Updates
6.9 GlaxoSmithKline
6.9.1 GlaxoSmithKline Corporation Information
6.9.2 GlaxoSmithKline Description and Business Overview
6.9.3 GlaxoSmithKline Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.9.4 GlaxoSmithKline Intramuscular HPV Vaccine Product Portfolio
6.9.5 GlaxoSmithKline Recent Developments/Updates
6.10 Johnson & Johnson
6.10.1 Johnson & Johnson Corporation Information
6.10.2 Johnson & Johnson Description and Business Overview
6.10.3 Johnson & Johnson Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Johnson & Johnson Intramuscular HPV Vaccine Product Portfolio
6.10.5 Johnson & Johnson Recent Developments/Updates
6.11 MedImmune
6.11.1 MedImmune Corporation Information
6.11.2 MedImmune Intramuscular HPV Vaccine Description and Business Overview
6.11.3 MedImmune Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.11.4 MedImmune Intramuscular HPV Vaccine Product Portfolio
6.11.5 MedImmune Recent Developments/Updates
6.12 Walvax Biotechnology
6.12.1 Walvax Biotechnology Corporation Information
6.12.2 Walvax Biotechnology Intramuscular HPV Vaccine Description and Business Overview
6.12.3 Walvax Biotechnology Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Walvax Biotechnology Intramuscular HPV Vaccine Product Portfolio
6.12.5 Walvax Biotechnology Recent Developments/Updates
6.13 Liaoning Chengda Biotechnology
6.13.1 Liaoning Chengda Biotechnology Corporation Information
6.13.2 Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Description and Business Overview
6.13.3 Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Product Portfolio
6.13.5 Liaoning Chengda Biotechnology Recent Developments/Updates
6.14 Hualan Biological Engineering
6.14.1 Hualan Biological Engineering Corporation Information
6.14.2 Hualan Biological Engineering Intramuscular HPV Vaccine Description and Business Overview
6.14.3 Hualan Biological Engineering Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Hualan Biological Engineering Intramuscular HPV Vaccine Product Portfolio
6.14.5 Hualan Biological Engineering Recent Developments/Updates
6.15 Sinovac Biotech
6.15.1 Sinovac Biotech Corporation Information
6.15.2 Sinovac Biotech Intramuscular HPV Vaccine Description and Business Overview
6.15.3 Sinovac Biotech Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Sinovac Biotech Intramuscular HPV Vaccine Product Portfolio
6.15.5 Sinovac Biotech Recent Developments/Updates
6.16 Chongqing Zhifei Biological Products
6.16.1 Chongqing Zhifei Biological Products Corporation Information
6.16.2 Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Description and Business Overview
6.16.3 Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Product Portfolio
6.16.5 Chongqing Zhifei Biological Products Recent Developments/Updates
6.17 Chang Chun High and New Technology Industries (Group)
6.17.1 Chang Chun High and New Technology Industries (Group) Corporation Information
6.17.2 Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Description and Business Overview
6.17.3 Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Product Portfolio
6.17.5 Chang Chun High and New Technology Industries (Group) Recent Developments/Updates
6.18 Beijing Wantai Biological Pharmacy Enterprise
6.18.1 Beijing Wantai Biological Pharmacy Enterprise Corporation Information
6.18.2 Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Description and Business Overview
6.18.3 Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Product Portfolio
6.18.5 Beijing Wantai Biological Pharmacy Enterprise Recent Developments/Updates
6.19 Jiangsu Recbio Technology
6.19.1 Jiangsu Recbio Technology Corporation Information
6.19.2 Jiangsu Recbio Technology Intramuscular HPV Vaccine Description and Business Overview
6.19.3 Jiangsu Recbio Technology Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Jiangsu Recbio Technology Intramuscular HPV Vaccine Product Portfolio
6.19.5 Jiangsu Recbio Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intramuscular HPV Vaccine Industry Chain Analysis
7.2 Intramuscular HPV Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intramuscular HPV Vaccine Production Mode & Process
7.4 Intramuscular HPV Vaccine Sales and Marketing
7.4.1 Intramuscular HPV Vaccine Sales Channels
7.4.2 Intramuscular HPV Vaccine Distributors
7.5 Intramuscular HPV Vaccine Customers
8 Intramuscular HPV Vaccine Market Dynamics
8.1 Intramuscular HPV Vaccine Industry Trends
8.2 Intramuscular HPV Vaccine Market Drivers
8.3 Intramuscular HPV Vaccine Market Challenges
8.4 Intramuscular HPV Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Intramuscular HPV Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Intramuscular HPV Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Intramuscular HPV Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Intramuscular HPV Vaccine Sales (Units) of Key Manufacturers (2018-2024)
Table 5. Global Intramuscular HPV Vaccine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Intramuscular HPV Vaccine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Intramuscular HPV Vaccine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Intramuscular HPV Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Intramuscular HPV Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Intramuscular HPV Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Intramuscular HPV Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Intramuscular HPV Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intramuscular HPV Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intramuscular HPV Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Intramuscular HPV Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Intramuscular HPV Vaccine Sales by Region (2018-2024) & (Units)
Table 18. Global Intramuscular HPV Vaccine Sales Market Share by Region (2018-2024)
Table 19. Global Intramuscular HPV Vaccine Sales by Region (2024-2029) & (Units)
Table 20. Global Intramuscular HPV Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Intramuscular HPV Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Intramuscular HPV Vaccine Revenue Market Share by Region (2018-2024)
Table 23. Global Intramuscular HPV Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Intramuscular HPV Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Intramuscular HPV Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Intramuscular HPV Vaccine Sales by Country (2018-2024) & (Units)
Table 27. North America Intramuscular HPV Vaccine Sales by Country (2024-2029) & (Units)
Table 28. North America Intramuscular HPV Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Intramuscular HPV Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Intramuscular HPV Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Intramuscular HPV Vaccine Sales by Country (2018-2024) & (Units)
Table 32. Europe Intramuscular HPV Vaccine Sales by Country (2024-2029) & (Units)
Table 33. Europe Intramuscular HPV Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Intramuscular HPV Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Intramuscular HPV Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Intramuscular HPV Vaccine Sales by Region (2018-2024) & (Units)
Table 37. Asia Pacific Intramuscular HPV Vaccine Sales by Region (2024-2029) & (Units)
Table 38. Asia Pacific Intramuscular HPV Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Intramuscular HPV Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Intramuscular HPV Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Intramuscular HPV Vaccine Sales by Country (2018-2024) & (Units)
Table 42. Latin America Intramuscular HPV Vaccine Sales by Country (2024-2029) & (Units)
Table 43. Latin America Intramuscular HPV Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Intramuscular HPV Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Intramuscular HPV Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Intramuscular HPV Vaccine Sales by Country (2018-2024) & (Units)
Table 47. Middle East & Africa Intramuscular HPV Vaccine Sales by Country (2024-2029) & (Units)
Table 48. Middle East & Africa Intramuscular HPV Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Intramuscular HPV Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Intramuscular HPV Vaccine Sales (Units) by Type (2018-2024)
Table 51. Global Intramuscular HPV Vaccine Sales (Units) by Type (2024-2029)
Table 52. Global Intramuscular HPV Vaccine Sales Market Share by Type (2018-2024)
Table 53. Global Intramuscular HPV Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Intramuscular HPV Vaccine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Intramuscular HPV Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Intramuscular HPV Vaccine Revenue Market Share by Type (2018-2024)
Table 57. Global Intramuscular HPV Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Intramuscular HPV Vaccine Price (US$/Unit) by Type (2018-2024)
Table 59. Global Intramuscular HPV Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Intramuscular HPV Vaccine Sales (Units) by Application (2018-2024)
Table 61. Global Intramuscular HPV Vaccine Sales (Units) by Application (2024-2029)
Table 62. Global Intramuscular HPV Vaccine Sales Market Share by Application (2018-2024)
Table 63. Global Intramuscular HPV Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Intramuscular HPV Vaccine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Intramuscular HPV Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Intramuscular HPV Vaccine Revenue Market Share by Application (2018-2024)
Table 67. Global Intramuscular HPV Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Intramuscular HPV Vaccine Price (US$/Unit) by Application (2018-2024)
Table 69. Global Intramuscular HPV Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. Merck Sharp & Dohme (MSD) Corporation Information
Table 71. Merck Sharp & Dohme (MSD) Description and Business Overview
Table 72. Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Product
Table 74. Merck Sharp & Dohme (MSD) Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Pfizer Intramuscular HPV Vaccine Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Sanofi Intramuscular HPV Vaccine Product
Table 84. Sanofi Recent Developments/Updates
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. GSK Intramuscular HPV Vaccine Product
Table 89. GSK Recent Developments/Updates
Table 90. Serum Institute Corporation Information
Table 91. Serum Institute Description and Business Overview
Table 92. Serum Institute Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Serum Institute Intramuscular HPV Vaccine Product
Table 94. Serum Institute Recent Developments/Updates
Table 95. Astellas Pharma Corporation Information
Table 96. Astellas Pharma Description and Business Overview
Table 97. Astellas Pharma Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Astellas Pharma Intramuscular HPV Vaccine Product
Table 99. Astellas Pharma Recent Developments/Updates
Table 100. CSL Corporation Information
Table 101. CSL Description and Business Overview
Table 102. CSL Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. CSL Intramuscular HPV Vaccine Product
Table 104. CSL Recent Developments/Updates
Table 105. Emergent BioSolutions Corporation Information
Table 106. Emergent BioSolutions Description and Business Overview
Table 107. Emergent BioSolutions Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Emergent BioSolutions Intramuscular HPV Vaccine Product
Table 109. Emergent BioSolutions Recent Developments/Updates
Table 110. GlaxoSmithKline Corporation Information
Table 111. GlaxoSmithKline Description and Business Overview
Table 112. GlaxoSmithKline Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. GlaxoSmithKline Intramuscular HPV Vaccine Product
Table 114. GlaxoSmithKline Recent Developments/Updates
Table 115. Johnson & Johnson Corporation Information
Table 116. Johnson & Johnson Description and Business Overview
Table 117. Johnson & Johnson Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Johnson & Johnson Intramuscular HPV Vaccine Product
Table 119. Johnson & Johnson Recent Developments/Updates
Table 120. MedImmune Corporation Information
Table 121. MedImmune Description and Business Overview
Table 122. MedImmune Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. MedImmune Intramuscular HPV Vaccine Product
Table 124. MedImmune Recent Developments/Updates
Table 125. Walvax Biotechnology Corporation Information
Table 126. Walvax Biotechnology Description and Business Overview
Table 127. Walvax Biotechnology Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Walvax Biotechnology Intramuscular HPV Vaccine Product
Table 129. Walvax Biotechnology Recent Developments/Updates
Table 130. Liaoning Chengda Biotechnology Corporation Information
Table 131. Liaoning Chengda Biotechnology Description and Business Overview
Table 132. Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Product
Table 134. Liaoning Chengda Biotechnology Recent Developments/Updates
Table 135. Hualan Biological Engineering Corporation Information
Table 136. Hualan Biological Engineering Description and Business Overview
Table 137. Hualan Biological Engineering Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Hualan Biological Engineering Intramuscular HPV Vaccine Product
Table 139. Hualan Biological Engineering Recent Developments/Updates
Table 140. Sinovac Biotech Corporation Information
Table 141. Sinovac Biotech Description and Business Overview
Table 142. Sinovac Biotech Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Sinovac Biotech Intramuscular HPV Vaccine Product
Table 144. Sinovac Biotech Recent Developments/Updates
Table 145. Chongqing Zhifei Biological Products Corporation Information
Table 146. Chongqing Zhifei Biological Products Description and Business Overview
Table 147. Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Product
Table 149. Chongqing Zhifei Biological Products Recent Developments/Updates
Table 150. Chang Chun High and New Technology Industries (Group) Corporation Information
Table 151. Chang Chun High and New Technology Industries (Group) Description and Business Overview
Table 152. Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Product
Table 154. Chang Chun High and New Technology Industries (Group) Recent Developments/Updates
Table 155. Beijing Wantai Biological Pharmacy Enterprise Corporation Information
Table 156. Beijing Wantai Biological Pharmacy Enterprise Description and Business Overview
Table 157. Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Product
Table 159. Beijing Wantai Biological Pharmacy Enterprise Recent Developments/Updates
Table 160. Jiangsu Recbio Technology Corporation Information
Table 161. Jiangsu Recbio Technology Description and Business Overview
Table 162. Jiangsu Recbio Technology Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Jiangsu Recbio Technology Intramuscular HPV Vaccine Product
Table 164. Jiangsu Recbio Technology Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Intramuscular HPV Vaccine Distributors List
Table 168. Intramuscular HPV Vaccine Customers List
Table 169. Intramuscular HPV Vaccine Market Trends
Table 170. Intramuscular HPV Vaccine Market Drivers
Table 171. Intramuscular HPV Vaccine Market Challenges
Table 172. Intramuscular HPV Vaccine Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Intramuscular HPV Vaccine
Figure 2. Global Intramuscular HPV Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Intramuscular HPV Vaccine Market Share by Type in 2022 & 2029
Figure 4. Bivalent Product Picture
Figure 5. Quadrivalent Product Picture
Figure 6. Nine-valent Product Picture
Figure 7. Global Intramuscular HPV Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Intramuscular HPV Vaccine Market Share by Application in 2022 & 2029
Figure 9. Male
Figure 10. Female
Figure 11. Global Intramuscular HPV Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Intramuscular HPV Vaccine Market Size (2018-2029) & (US$ Million)
Figure 13. Global Intramuscular HPV Vaccine Sales (2018-2029) & (Units)
Figure 14. Global Intramuscular HPV Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 15. Intramuscular HPV Vaccine Report Years Considered
Figure 16. Intramuscular HPV Vaccine Sales Share by Manufacturers in 2022
Figure 17. Global Intramuscular HPV Vaccine Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Intramuscular HPV Vaccine Players: Market Share by Revenue in 2022
Figure 19. Intramuscular HPV Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Intramuscular HPV Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Intramuscular HPV Vaccine Sales Market Share by Country (2018-2029)
Figure 22. North America Intramuscular HPV Vaccine Revenue Market Share by Country (2018-2029)
Figure 23. United States Intramuscular HPV Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Intramuscular HPV Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Intramuscular HPV Vaccine Sales Market Share by Country (2018-2029)
Figure 26. Europe Intramuscular HPV Vaccine Revenue Market Share by Country (2018-2029)
Figure 27. Germany Intramuscular HPV Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Intramuscular HPV Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Intramuscular HPV Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Intramuscular HPV Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Intramuscular HPV Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Intramuscular HPV Vaccine Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Intramuscular HPV Vaccine Revenue Market Share by Region (2018-2029)
Figure 34. China Intramuscular HPV Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Intramuscular HPV Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Intramuscular HPV Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Intramuscular HPV Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Intramuscular HPV Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Intramuscular HPV Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Intramuscular HPV Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Intramuscular HPV Vaccine Sales Market Share by Country (2018-2029)
Figure 42. Latin America Intramuscular HPV Vaccine Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Intramuscular HPV Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Intramuscular HPV Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Intramuscular HPV Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Colombia Intramuscular HPV Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Intramuscular HPV Vaccine Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Intramuscular HPV Vaccine Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Intramuscular HPV Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Intramuscular HPV Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Intramuscular HPV Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Intramuscular HPV Vaccine by Type (2018-2029)
Figure 53. Global Revenue Market Share of Intramuscular HPV Vaccine by Type (2018-2029)
Figure 54. Global Intramuscular HPV Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Intramuscular HPV Vaccine by Application (2018-2029)
Figure 56. Global Revenue Market Share of Intramuscular HPV Vaccine by Application (2018-2029)
Figure 57. Global Intramuscular HPV Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 58. Intramuscular HPV Vaccine Value Chain
Figure 59. Intramuscular HPV Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed